Read More 1 minute read Analyst Ratings Initiation News Price Target Guggenheim Initiates Coverage On Confluent with Buy Rating, Announces Price Target of $29 By Benzinga Newsdesk January 27, 5:58 AM Guggenheim analyst Howard Ma initiates coverage on Confluent (NASDAQ:CFLT) with a Buy rating and announces Price Target of $29. CFLT
Read More 1 minute read Analyst Ratings Initiation News Price Target Guggenheim Initiates Coverage On Couchbase with Buy Rating, Announces Price Target of $20 By Benzinga Newsdesk January 27, 5:54 AM Guggenheim analyst Howard Ma initiates coverage on Couchbase (NASDAQ:BASE) with a Buy rating and announces Price Target of $20. BASE
Read More 1 minute read Analyst Ratings Initiation News Price Target Stifel Initiates Coverage On Compass Therapeutics with Buy Rating, Announces Price Target of $9 By Benzinga Newsdesk January 27, 5:50 AM Stifel analyst Stephen Willey initiates coverage on Compass Therapeutics (NASDAQ:CMPX) with a Buy rating and announces Price Target of $9. CMPX
Read More 1 minute read Analyst Color Analyst Ratings Gaming General Initiation Why This Roblox Analyst Prefers To Be On The Sidelines By Priya Nigam January 26, 1:19 PM Shares of Roblox Corp (NYSE: RBLX) started Thursday with a steep decline, giving up gains recorded in the previous trading session. RBLX
Read More 2 minute read Analyst Color Analyst Ratings Initiation News Price Target Concerns Over Tinder’s Prospects Despite Match’s Multiple Catalysts Keeps Analyst At Sidelines By Anusuya Lahiri January 26, 1:15 PM Citigroup analyst Ygal Arounian initiated coverage on Match Group Inc (NASDAQ:MTCH) with a Neutral rating and a price target of $55. Match… MTCH
Read More 1 minute read Analyst Color Analyst Ratings Initiation News Tech Top Stories Could Datadog’s TAM Reach $62B — Maybe $70B? Yes, But It Depends On This: Analyst By Priya Nigam January 26, 1:07 PM Shares of Datadog Inc (NASDAQ: DDOG) spiked during Thursday’s early trading session. DDOG
Read More 1 minute read Analyst Ratings Initiation News Price Target Chardan Capital Initiates Coverage On Coya Therapeutics with Buy Rating, Announces Price Target of $9 By Benzinga Newsdesk January 26, 7:25 AM Chardan Capital analyst Keay Nakae initiates coverage on Coya Therapeutics (NASDAQ:COYA) with a Buy rating and announces Price Target of $9. COYA
Read More 1 minute read Analyst Ratings Initiation News Price Target Wolfe Research Initiates Coverage On DexCom with Outperform Rating, Announces Price Target of $121 By Benzinga Newsdesk January 26, 6:49 AM Wolfe Research analyst Mike Polark initiates coverage on DexCom (NASDAQ:DXCM) with a Outperform rating and announces Price Target of $121. DXCM
Read More 1 minute read Analyst Ratings Initiation News Wolfe Research Initiates Coverage On Insulet with Peer Perform Rating By Benzinga Newsdesk January 26, 6:48 AM Wolfe Research analyst Mike Polark initiates coverage on Insulet (NASDAQ:PODD) with a Peer Perform rating. PODD
Read More 1 minute read Analyst Ratings Initiation News Price Target Cantor Fitzgerald Initiates Coverage On Datadog with Overweight Rating, Announces Price Target of $95 By Benzinga Newsdesk January 26, 5:42 AM Cantor Fitzgerald analyst Jonathan Ruykhaver initiates coverage on Datadog (NASDAQ:DDOG) with a Overweight rating and announces Price Target of $95. DDOG